MEDICEO CORP
MEDICEO CORP, headquartered in Japan, is a prominent player in the pharmaceutical and healthcare industry, specialising in the development and distribution of innovative medical products. Founded in 2000, the company has established a strong presence in key operational regions across Asia and beyond, focusing on enhancing patient care through advanced therapeutic solutions. With a diverse portfolio that includes prescription medications and over-the-counter products, MEDICEO CORP is recognised for its commitment to quality and efficacy. The company’s unique approach to research and development has led to several notable achievements, positioning it as a trusted name in the market. As a leader in the pharmaceutical sector, MEDICEO CORP continues to drive advancements that improve health outcomes and meet the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does MEDICEO CORP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MEDICEO CORP's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MEDICEO CORP's reported carbon emissions
As of the latest available data from 2019, MEDICEO CORP reported total carbon emissions of approximately 12,000,000 kg CO2e. This figure includes 5,063,000 kg CO2e from Scope 1 emissions, 6,155,000 kg CO2e from Scope 2 emissions, and 1,179,000 kg CO2e from Scope 3 emissions. Despite the significant emissions figures, there are currently no disclosed reduction targets or initiatives aimed at decreasing these emissions. MEDICEO CORP has not committed to any specific climate pledges or science-based targets, indicating a potential area for improvement in their climate strategy. Overall, while the company has maintained consistent emissions levels over the years, the absence of reduction commitments highlights the need for a more proactive approach to climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| Scope 1 | 5,063,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 6,155,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 1,179,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MEDICEO CORP is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
